The potential of Sijunzi decoction in the fight against gastrointestinal disorders: a review

Liangjun Yang, Zheng Fang, Jia-Jie Zhu, Xiaofang Li, Bo Yang, Haiyan Liu, Feiyan LouFrontiers in Pharmacology 2025 · DOI

TL;DR

Sijunzi Decoction (SJZD), a traditional Chinese medicine formula, shows significant promise in treating a range of gastrointestinal disorders, from functional dyspepsia to gastric and colorectal cancers. This review synthesizes current research, highlighting SJZD's multifaceted mechanisms of action, including gut flora regulation, anti-inflammation, immune modulation, and mucosal repair, offering a comprehensive understanding of its therapeutic potential.

What Problem Does This Paper Address?

Gastrointestinal disorders represent a significant global health burden, affecting a large portion of the population and leading to considerable morbidity and healthcare costs. While Western medicine offers treatments, many gastrointestinal conditions remain challenging to manage effectively, often due to unclear etiologies or unsatisfactory treatment outcomes. Traditional Chinese Medicine (TCM), with its holistic approach, has a long history of addressing these issues. Sijunzi Decoction (SJZD), a well-established TCM formula, has demonstrated clinical efficacy in various gastrointestinal ailments. However, a comprehensive understanding of its precise mechanisms of action, bridging clinical observations with underlying biological processes, has been lacking. This paper aims to bridge this gap by systematically reviewing and synthesizing existing clinical and experimental evidence on SJZD's applications and mechanisms in treating gastrointestinal disorders.

Methods

This paper is a systematic review of existing literature. The authors conducted a comprehensive search for publications on PubMed and ScienceDirect, focusing on articles written in English. The primary keyword used was "sijunzi." The inclusion criteria encompassed a broad range of study types, including randomized controlled trials, systematic and narrative reviews, observational studies, nonclinical studies, case reports, and expert opinions published between 2000 and 2024. Studies that were protocols, duplicate articles, or conference abstracts were excluded. The review then synthesizes the findings from these studies to describe the clinical applications and mechanistic underpinnings of SJZD.

Datasets

Not discussed in the paper. This is a review article that synthesizes existing research rather than presenting new experimental data or datasets.

Key Insights and Ideas

  • Holistic Approach of TCM: SJZD exemplifies the multicomponent, multi-target, and multi-pathway approach of TCM, offering a more integrated way to address complex gastrointestinal diseases compared to single-target Western medicine.
  • Gut Microbiota as a Key Target: A significant insight is SJZD's ability to positively modulate the gut microbiota, restoring balance and potentially influencing various gastrointestinal functions and immune responses. This highlights the growing importance of the gut microbiome in disease pathogenesis and treatment.
  • Synergistic Action of Herbs: The paper emphasizes that the efficacy of SJZD stems from the synergistic interaction of its four constituent herbs (Panax ginseng, Wolfiporia cocos, Atractylodes macrocephala, and Glycyrrhiza uralensis), each contributing unique properties to the overall therapeutic effect.
  • Broad Spectrum of Action: SJZD doesn't just target one aspect of disease; it acts on multiple fronts, including inflammation, immune regulation, and tissue repair, making it a versatile therapeutic agent for diverse gastrointestinal conditions.

Key Results

The review highlights SJZD's efficacy across a spectrum of gastrointestinal disorders:

  • Functional Dyspepsia (FD): Meta-analyses suggest SJZD-based prescriptions are effective in alleviating FD symptoms with no significant adverse effects.
  • Chronic Gastritis: SJZD has been shown to improve histopathology, increase H. pylori clearance rates, and alleviate symptoms. Network pharmacology predicts it can suppress inflammation.
  • Gastric Cancer: SJZD has been used for long-term treatment, showing potential in managing precachexia, improving nutritional status, and inhibiting cancer cell growth and apoptosis. It may also upregulate CMTM2 expression, a gene involved in tumor progression.
  • Irritable Bowel Syndrome (IBS): Modified SJZD, particularly in combination with other TCM formulas, shows enhanced clinical effectiveness for IBS-D. Experimental studies indicate SJZD can restore gut microbiota balance and improve neurotransmitter metabolism.
  • Colorectal Cancer: SJZD has shown potential in influencing protein binding, inducing apoptosis and autophagy, and potentially acting as a therapeutic option for colorectal cancer.
  • Ulcerative Colitis (UC): SJZD has demonstrated effectiveness in restoring microbial homeostasis, enhancing the intestinal barrier, and modulating immune responses, leading to mucosal repair and reduced inflammation.

The primary mechanisms identified include:

  • Regulating Intestinal Flora: SJZD promotes beneficial bacteria like Lactobacillus and Bifidobacterium while reducing pathogenic ones.
  • Anti-inflammation: It alleviates local and systemic inflammation by reducing pro-inflammatory cytokines.
  • Regulating Immune Response: SJZD modulates immune function, enhancing macrophage activity and influencing T-cell populations.
  • Promoting Intestinal Mucosal Restitution: It aids in repairing the intestinal barrier, enhancing mucin secretion, and promoting epithelial cell migration.

Limitations and Future Work

The authors acknowledge several limitations:

  • Limited Prospective, Multi-center, Large-Sample Studies: While evidence exists, there's a need for more rigorous, large-scale clinical trials to further validate SJZD's efficacy and safety.
  • Lack of Interaction Studies: As a compound prescription, there's a scarcity of research investigating the specific interactions and synergistic effects among the individual components of SJZD.
  • Focus on Individual Components: Much of the mechanistic research focuses on either the entire formula or individual herbs/monomers, with less emphasis on how these components work together.

Future work should prioritize:

  • Clinical Translation: Further investigation into the clinical translation of SJZD, providing robust evidence for its application in preventing and treating gastrointestinal inflammatory diseases, functional disorders, and tumors.
  • Mechanistic Elucidation: Deeper exploration of the synergistic mechanisms between the components of SJZD and their interactions with the host's biological systems.
  • Standardized Research: Encouraging the development and implementation of standardized, large-scale, and rigorously designed RCTs to solidify the evidence base.

Summary updated

Abstract

Sijunzi Decoction (SJZD) is a traditional Chinese medicine formula widely used in the treatment of gastrointestinal disorders. Clinical studies have substantiated the efficacy of SJZD in managing conditions such as functional dyspepsia, chronic gastritis, gastric cancer, irritable bowel syndrome, colorectal cancer, and ulcerative colitis. Despite its proven effectiveness, the precise mechanisms by which SJZD operates remain incompletely understood. In this study, we undertake a systematic review of both the clinical applications and the mechanistic underpinnings of SJZD in the context of gastrointestinal disease treatment. Research indicates that SJZD functions through a spectrum of mechanisms including the regulation of intestinal flora, alleviation of inflammation, modulation of immune responses, and facilitation of mucosal repair in the treatment of gastrointestinal ailments. This comprehensive analysis aims to provide a clearer understanding of how SJZD benefits patients with gastrointestinal disorders.
BibTeX
@inproceedings{yang2025potential,
  author = {Liangjun Yang and Zheng Fang and Jia-Jie Zhu and Xiaofang Li and Bo Yang and Haiyan Liu and Feiyan Lou},
  title = {{The potential of Sijunzi decoction in the fight against gastrointestinal disorders: a review}},
  booktitle = {Frontiers in Pharmacology},
  year = {2025},
  doi = {10.3389/fphar.2025.1464498},
}
Figure